Validation of the VIRSTA and VIRSTA+ Scores to Identify Patients with Staphylococcus aureus Bacteremia at Very Low Risk of Infective Endocarditis [0.03%]
Daniela Malano-Barletta,Miguel Ángel Verdejo,Guillermo Cuervo et al.
Daniela Malano-Barletta et al.
Introduction: Adherence to guideline recommendations on the use of echocardiography in all patients with Staphylococcus aureus bacteremia (SAB) is heterogeneous. This study aims to validate the VIRSTA and VIRSTA+ scores a...
Francelise Bridi Cavassin,Laura Fernanda Rodrigues,Camila Vitoria Rosa de Souza et al.
Francelise Bridi Cavassin et al.
Background: Amphotericin B (AmB) remains the gold standard for treating invasive fungal infections, yet its clinical utility is frequently constrained by systemic nephrotoxicity. Localized administration routes have emerg...
Correction: The Cefazolin Inoculum Effect: An Underappreciated Factor in MSSA Treatment Strategies [0.03%]
关于头孢唑林的最小抑菌浓度人工降低现象：一个被忽视的耐甲氧西林阴性的金黄色葡萄球菌治疗策略因素
Prakhar Srivastava,Elizabeth Singleton,Taylor Morrisette et al.
Prakhar Srivastava et al.
Published Erratum
Infectious diseases and therapy. 2026 Apr 17. DOI:10.1007/s40121-026-01347-y 2026
Epidemiology of Acute Cystitis or Afebrile Urinary Tract Infection in Adult Men: A Systematic Literature Review [0.03%]
成人男性急性膀胱炎或无发热性尿路感染的流行病学：系统文献回顾
Mary E Georgiou,Priscilla Wittkopf,Amber L Martin et al.
Mary E Georgiou et al.
Introduction: Updated Infectious Diseases Society of America guidelines for urinary tract infections (UTIs) have reclassified UTI in men without signs of systemic infection, with/without anatomical abnormalities of the ur...
Estimation of Costs Related to the Management of Herpes Zoster and its Complications in Vietnam: A Medical Chart Review [0.03%]
越南带状疱疹及相关并发症的卫生经济负担：医学图表审议研究
Nurilign Ahmed,Van M Nguyen,Anh C Pham et al.
Nurilign Ahmed et al.
Introduction: Herpes zoster (HZ) represents a significant health and economic burden in Vietnam, driven by direct medical costs and influenced by patient's age, comorbidities, immunodeficiency, and HZ complications, inclu...
Cost-Effectiveness of Alternative Immunization Strategies to Protect Infants Against Respiratory Syncytial Virus in Germany: A Decision Modeling Study [0.03%]
在德国保护婴儿免受呼吸道合胞病毒侵害的替代免疫策略的成本效益分析：一项决定模型研究
Caroline Lade,Erin Quinn,Lea J Bayer et al.
Caroline Lade et al.
Introduction: Germany's Standing Committee on Vaccination (STIKO) recommends the use of monoclonal antibody nirsevimab for infants in their first respiratory syncytial virus (RSV) season; however, incorporating RSVpreF ma...
Burden of Respiratory Syncytial Virus in Older ADults in Nagasaki, Japan (Nagasaki ROAD): Preliminary Results (April 2024-March 2025) of a Prospective, Multicenter, Epidemiological Study [0.03%]
日本长崎老年人呼吸道合胞病毒负担的初步结果（2024年4月-2025年3月）：一项前瞻性多中心流行病学研究的成果（长崎ROAD研究）
Takahiro Takazono,Norihito Kaku,Naoki Hosogaya et al.
Takahiro Takazono et al.
Introduction: Older adults (OAs) and individuals with underlying comorbidities are at increased risk for severe respiratory syncytial virus (RSV) disease (e.g., lower respiratory tract disease [LRTD]) and related adverse ...
Antibiotic Pharmacokinetics and Prostate Penetration in Bacterial Prostatitis: A Systematic Review [0.03%]
抗生素药代动力学和前列腺穿透在细菌性前列腺炎中的作用：系统评价
Rui Ge,Xinwen Nian,Benjuan Liu et al.
Rui Ge et al.
Background: Effective treatment of bacterial prostatitis is limited by poor antibiotic penetration into prostatic tissue due to anatomical and physiological barriers, including the blood-prostate barrier, pH-dependent ion...
Efficacy and Safety of Glecaprevir/Pibrentasvir in Participants with Chronic HCV Infection and Comorbidities or Multiple Concomitant Medications: An Integrated Analysis [0.03%]
吉利德公司索非布韦联合雷迪帕韦治疗慢性丙型肝炎病毒感染合并其他疾病或多种伴随用药患者的疗效和安全性：综合分析
Curtis Cooper,Shweta A Raina,Lisa Johnson et al.
Curtis Cooper et al.
Introduction: Glecaprevir/pibrentasvir (G/P) is globally approved for the treatment of chronic hepatitis C virus (HCV) infection and for acute HCV infection in the USA. The efficacy and safety of G/P has been clinically d...
Lucinda J Van Anglen,Cathy L Koo,Kimberly A Couch
Lucinda J Van Anglen
Introduction: Omadacycline is indicated for the treatment of acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia. With limited real-world data, we report the clinical experience a...